help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Conconi, M. V.
Right arrow Articles by Walker, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Conconi, M. V.
Right arrow Articles by Walker, A. M.

Endocrinology, Vol 114, 725-734, Copyright © 1984 by Endocrine Society

ARTICLES

Chloroquine affects prolactin secretion and Golgi morphology in the mammotroph

MV Conconi and AM Walker

Chloroquine is widely used as a lysosomal enzyme inhibitor, and while effects on DNA repair and membrane recycling have also been reported, there has been no investigation of effects on the processing of secretory products. To determine whether chloroquine had any effect on secretion and secretory organelles, we monitored the effects of low concentrations (10(-6) M) of chloroquine on a cell population which normally secretes copious amounts of a simple polypeptide (PRL) in vitro and in which there exists a subpopulation of cells which releases PRL very rapidly after synthesis. Cultured anterior pituitary cells were exposed to 10(-6) M chloroquine for 6, 12, 24, or 48 h. At these times, the culture medium was used for determination of PRL content and beta-glucuronidase activity, and the cells were used for determination of DNA content and level of beta-glucuronidase activity or for electron microscopy. Treatment with 10(-6) M chloroquine resulted in 20-40% inhibition of PRL release (maximum inhibition at any dose), no change in the total amount of beta-glucuronidase activity, and a number of ultrastructural changes in the Golgi region consistent with an accumulation of chloroquine within the cisternae and immature granules. The effects of chloroquine on Golgi morphology were unaltered by cotreatment with 50 micrograms/ml cycloheximide, and chloroquine had no affect on PRL synthesis. These results are consistent with an adverse effect of chloroquine on packaging of PRL into immature granules in the Golgi apparatus, without any effect on the release of mature secretory granules.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
S. M. Weber, J.-M. Chen, and S. M. Levitz
Inhibition of Mitogen-Activated Protein Kinase Signaling by Chloroquine
J. Immunol., May 15, 2002; 168(10): 5303 - 5309.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
F Blanco-Favela, M. G Quintal, A K Chavez-Rueda, A Leanos-Miranda, R Berron-Peres, V Baca-Ruiz, and C Lavalle-Montalvo
Anti-prolactin autoantibodies in paediatric systemic lupus erythematosus patients
Lupus, November 1, 2001; 10(11): 803 - 808.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1984 by The Endocrine Society